At a recent biotech conference, we heard a speaker start his remarks by pointing to the "threat from Asia." He talked about the large number of Ph.D.'s in molecular biology now being trained in China and felt certain that the next stage would be an attempt by Chinese companies to move strongly into the development of new medicines. To the speaker, this was anathema.
But think about that for a moment. Right now, bright young Chinese students are studying hard at their universities. In a few years, they'll burn the midnight oil at Chinese biotech companies or research institutes. They'll work for another dozen years doing experiments and clinical trials—all so they can invent new drugs, which may save millions of lives. How mad should we be?
To read the full, original article click on this link: Asia's High-Tech Boom Is Good for Us, Too - WSJ.com
Author:
NATHAN MYHRVOLD and EDWARD JUNG
